Less than a year after putting down $240 million to acquire of Ivenix and its sensor- and software-backed infusion pump, Fresenius Kabi is recalling more than 1,500 of them. The recall affects only ...
10-Year Collaboration Will Support Growing Global Demand for the INTERCEPT Blood System and Help Expand Access to Pathogen-Reduced Blood Components to Patients CONCORD, Calif.--(BUSINESS WIRE)--Cerus ...
Manitoba's cancer authority has stopped using an infusion pump line — made by a company whose IV pumps have been the subject of recalls — over concerns about leakage and the increased risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results